1. Chang HC, Kuo TT, Chen YY, Lin YJ, Chang HY, Hung CL, Chung FP. Sodium-Glucose Cotransporter 2 Inhibitors in Cardiovascular and Renal Outcomes in Patients With Diabetes but Without Established Cardiovascular Disease: A Nationwide Population-Based Cohort Study. Diabetes Care. 2022 ;45(9):129-130.
2. Hung PF, Chung FP, Hung CL, et al. Decreased Expression of Plakophilin-2 and αT-Catenin in Arrhythmogenic Right Ventricular Cardiomyopathy: Potential Markers for Diagnosis. Int J Mol Sci. 2022 ;23(10):5529.
3. Lin CY, Chung FP, Lin YJ, et al. Clinical Significance of J Waves With Respect to Substrate Characteristics and Ablation Outcomes in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy. Europace. 2021;23(9):1418-1427.
4. Chung FP, Lin CY, Shirai Y, et al. Outcomes of catheter ablation of ventricular arrhythmia originating from the left ventricular summit: A multicenter study. Heart Rhythm. 2020 ;17(7):1077-1083.
5. Chung FP, Lin CY, Lin YJ, et al. The Application of Noninvasive Signal-averaged Electrocardiogram Analysis in Predicting the Requirement of Epicardial Ablation in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy. Heart Rhythm. 2020 ;17(4):584-591.

限於篇幅,以上謹為代表著作